Literature DB >> 30343388

Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population.

Xiao-Nv Xie1,2, Jing Yu1,2, Li-Hua Zhang1,2, Zhi-Ying Luo1,2, Dong-Sheng Ouyang1,2, Ling-Jie Zheng1,2, Chun-Yang Wang1,2, Li Yang1,2, Ling Chen3, Zhi-Rong Tan4,5.   

Abstract

This study aimed to investigate the relationship between polymorphisms in the lipid metabolism-related gene PLA2G16 encoding Group XVI phospholipase A2 and the risk of colorectal cancer (CRC) in the Chinese population. A total of 185 patients with CRC and 313 healthy controls were enrolled. Thirteen single nucleotide polymorphisms (SNPs) of PLA2G16 were genotyped with SNPscan™. Linkage disequilibrium and haplotypes were analysed using Haploview software. Multivariate logistic regression was used to determine the association between the various genotypes and CRC risk. We identified five PLA2G16 SNPs (rs11600655, rs3809072, rs3809073, rs640908 and rs66475048) that were associated with CRC risk after adjusting for age, sex and body mass index. Two haplotypes (CTC and GGA) of rs11600655, rs3809073 and rs3809072, were relevant to CRC risk. The rs11600655 polymorphism was also associated with lymph node metastasis and CRC staging, while rs3809073 and rs3809072 may affect transcriptional regulation of PLA2G16 by altering transcription factor binding. These findings suggest that PLA2G16 polymorphisms-especially CTC and GGA haplotypes-increase CRC susceptibility. Importantly, we showed that the rs11600655 CC, rs640908 CT and rs66475048 GA genotypes are independent risk factors for CRC in the Chinese population.

Entities:  

Keywords:  Colorectal cancer; Lipid metabolism; PLA2G16; Polymorphism; Susceptibility

Mesh:

Substances:

Year:  2018        PMID: 30343388     DOI: 10.1007/s10142-018-0642-8

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  45 in total

1.  Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs.

Authors:  C J Yuan; A K Mandal; Z Zhang; A B Mukherjee
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

Review 2.  Transcriptional regulation: cancer, neurons and the REST.

Authors:  Judy M Coulson
Journal:  Curr Biol       Date:  2005-09-06       Impact factor: 10.834

3.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

4.  Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

Authors:  Maria Domenica Castellone; Hidemi Teramoto; Bart O Williams; Kirk M Druey; J Silvio Gutkind
Journal:  Science       Date:  2005-11-17       Impact factor: 47.728

5.  Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells.

Authors:  Irina Nazarenko; Reinhold Schäfer; Christine Sers
Journal:  J Cell Sci       Date:  2007-03-20       Impact factor: 5.285

6.  H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling.

Authors:  Irina Nazarenko; Glen Kristiansen; Sabine Fonfara; Raphaela Guenther; Cornelia Gieseler; Wolfgang Kemmner; Reinhold Schafer; Iver Petersen; Christine Sers
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.

Authors:  Christine Sers; Knut Husmann; Irina Nazarenko; Steffen Reich; Kai Wiechen; Bakhyt Zhumabayeva; Punam Adhikari; Katharina Schröder; Artur Gontarewicz; Reinhold Schäfer
Journal:  Oncogene       Date:  2002-04-25       Impact factor: 9.867

8.  The relationship between cyclooxygenase-2 expression and colorectal cancer.

Authors:  K M Sheehan; K Sheahan; D P O'Donoghue; F MacSweeney; R M Conroy; D J Fitzgerald; F E Murray
Journal:  JAMA       Date:  1999-10-06       Impact factor: 56.272

9.  Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.

Authors:  Dingzhi Wang; Haibin Wang; Qiong Shi; Sharada Katkuri; Walter Walhi; Beatrice Desvergne; Sanjoy K Das; Sudhansu K Dey; Raymond N DuBois
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

10.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.

Authors:  Dingzhi Wang; Haibin Wang; Joanne Brown; Takiko Daikoku; Wei Ning; Qiong Shi; Ann Richmond; Robert Strieter; Sudhansu K Dey; Raymond N DuBois
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  2 in total

1.  Identification of key pathways and genes in colorectal cancer to predict the prognosis based on mRNA interaction network.

Authors:  Hengzhou Zhu; Yi Ji; Wenting Li; Mianhua Wu
Journal:  Oncol Lett       Date:  2019-08-01       Impact factor: 2.967

2.  The role of PEG3 in the occurrence and prognosis of colon cancer.

Authors:  Ting Zhou; Wei Lin; Qiongni Zhu; Helen Renaud; Xiaowei Liu; Ruidong Li; Cui Tang; Chong Ma; Tai Rao; Zhirong Tan; Ying Guo
Journal:  Onco Targets Ther       Date:  2019-07-25       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.